SEC Tracker
Get the app
PGNY · XBRL financial data

Progyny financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (PGNY's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers280,891269,940278,078304,087286,625298,431324,038332,874313,346318,403328,504350,511
Cost of goods and services sold218,267213,046215,672235,806227,381234,999248,243253,901240,511241,522245,433261,210
Gross profit62,62456,89462,40668,28159,24463,43275,79578,97372,83576,88183,07189,301
Research and development——————1,5002,3002,6003,100*2,8003,300
General and administrative29,52428,18328,42931,17330,32932,02933,83936,21033,37343,67230,80831,224
Total operating expenses44,43543,09443,88347,59446,78647,64551,62554,61551,30861,65947,69249,298
Operating income (loss)18,18913,80018,52320,68712,45815,78724,17024,35821,52715,22235,37940,003
Other income (expense)1,7081,7203,3603,5645,5041,8712,3672,7192,4372,6321,5041,134
Income tax expense (benefit)5,0332,7925,6178,5827,5417,12611,4789,96510,1005,36912,65113,085
Net income (loss)15,89813,47016,89816,48510,42110,53215,05917,11213,86412,48524,23228,052
Earnings per share, basic USD per share0.170.140.180.180.120.120.180.200.160.150.300.36
Earnings per share, diluted USD per share0.160.130.170.170.110.120.170.190.150.140.290.34
Weighted average shares, basic thousands of shares95,50295,98096,48593,86890,06885,80985,49985,76686,01785,23280,92178,165
Weighted average shares, diluted thousands of shares100,880100,748101,05397,84093,82288,91589,30889,63990,22689,46584,75582,141

Balance sheet

CSV

Fiscal quarters (PGNY's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents158,07597,296114,95994,96091,480162,314109,239132,506133,982112,238131,607152,632
Marketable securities177,477273,791256,872167,228144,24065,640146,884172,586211,225197,85893,50484,293
Accounts receivable268,766241,869297,209293,796280,724235,324299,743271,853252,502220,287263,613257,476
Prepaid and other current assets6,95427,45112,47226,25929,8589,44311,82617,45724,30421,39212,82718,617
Total current assets611,272640,407681,512582,243546,302472,721567,692594,402622,013551,775501,551513,018
Property and equipment, net9,71610,21310,23410,63711,92812,38315,74019,94324,74229,92735,70941,992
Right-of-use asset18,02817,60517,18117,80617,43917,25126,94926,42325,68024,99024,27523,577
Goodwill11,88011,88011,88015,60615,79615,53419,65119,96319,96419,97819,87919,853
Total assets726,512756,620794,304698,632659,972607,102730,285760,950795,227742,435698,337715,836
Accounts payable132,040125,426130,171151,747130,46395,097145,713140,517123,089124,071157,826152,050
Total current liabilities193,419185,950205,919225,375208,471168,627237,128220,423210,493202,391235,742240,084
Lease liability, non-current17,70017,24116,78117,06416,62516,41325,99825,50524,73024,00023,25122,495
Total liabilities211,119203,191222,700242,439225,096185,040263,126245,928235,223226,391258,993262,579
Retained earnings76,50189,971106,869123,354133,775144,307159,366176,478190,342202,827227,059255,111
Total stockholders' equity515,393553,429571,604456,193434,876422,062467,159515,022560,004516,044439,344453,257
Total liabilities and equity726,512756,620794,304698,632659,972607,102730,285760,950795,227742,435698,337715,836
Common shares outstanding (cover page) thousands of shares95,83696,49995,22190,27685,15385,41385,71885,98286,21281,90278,33276,727

Cash flows

CSV

Fiscal quarters (PGNY's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)15,89813,47016,89816,48510,42110,53215,05917,11213,86412,48524,23228,052
Stock-based compensation31,251*28,799*31,05233,036*33,183*30,859*32,51232,383*32,173*34,799*19,72120,478*
Depreciation and amortization579*634*716754*837*868*1,1081,205*1,268*1,367*1,4831,623*
Net cash from operating activities54,182*37,659*25,73256,694*44,515*52,164*49,80855,510*50,671*54,203*45,94950,425*
Purchases of property and equipment953*681*850866*1,794*1,895*2,8435,269*4,684*5,614*6,3476,219*
Net cash from investing activities(64,315)*(93,414)*19,34486,096*15,362*74,990*(94,610)(29,915)*(42,744)*8,256*96,5943,552*
Share repurchases0*0*23,764159,959*61,453*55,102*00*0*81,657*118,60730,023*
Net cash from financing activities(2,362)*(5,025)*(27,411)(162,789)*(63,353)*(56,327)*(3,288)(2,329)*(5,486)*(88,259)*(123,114)(32,894)*
Net change in cash(12,495)*(60,779)*17,663(19,999)*(3,480)*70,834*(48,075)23,303*2,438*(25,787)*19,37821,032*

Compare with peers

SIC 8090 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 8090 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingQuarter
Progyny152,632350,51150,425*76.7M 10-QJun 30, 2026
Acadia Healthcare Company163,307895,30997,883*93.0M 10-QSep 30, 2026
Sotera Health412,384324,886110,549*285.6M 10-QSep 30, 2026
Concentra Group Holdings Parent158,038606,030135,210*127.5M 10-QJun 30, 2026
agilon health174,3991,519,48649,872*16.8M 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.